Teva Pharmaceutical Industries Limited Ordinary Shares financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Sep 2026Filed 03/11/2026 | Jun 2026Filed 29/07/2026 | Mar 2026Filed 29/04/2026 | Dec 2025Filed 03/02/2026 | Sep 2025Filed 03/11/2026 | Jun 2025Filed 29/07/2026 | Mar 2025Filed 29/04/2026 | Sep 2024Filed 05/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $4,395 | $4,142 | $3,982 | $1,500 | $4,480 | $4,176 | $3,891 | $4,332 | |
| $233 | −$576 | $369 | — | $433 | $282 | $214 | −$437 | |
| $0.20 | −$0.49 | $0.31 | — | $0.37 | $0.24 | $0.18 | −$0.39 | |
| 1,183 | 1,165 | 1,179 | — | 1,164 | 1,161 | 1,159 | 1,133 |
Trend